12
Participants
Start Date
August 29, 2016
Primary Completion Date
August 15, 2019
Study Completion Date
August 15, 2019
Albutein 5%
Albutein is manufactured from human plasma. The dose of Albutein 5% for replacement following plasma removal will be calculated based on gender, weight, and the hematocrit of the participant.
Plasma Exchange
Plasma Exchange will be performed using albutein 5% as the replacement solution.
Dartmouth-Hitchcock Medical Center, Lebanon
Lead Sponsor
Grifols Biologicals, LLC
INDUSTRY
Grifols Therapeutics LLC
INDUSTRY